Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study.
Barbara SkopecZuzana SninskaNikolai TzvetkovVladlen IvanushkinKatja BjörklöfJane HippenmeyerGeorgi MihaylovPublished in: Hematology (Amsterdam, Netherlands) (2021)
These findings support the utilization of romiplostim in patients with newly diagnosed and persistent ITP in accordance with recent guidelines and the recent romiplostim label extension.